Real-World Performance of the MiniMed 780G Advanced Hybrid Closed-Loop System in the Middle East, North Africa, and Türkiye Region [0.03%]
MiniMed 780G高级混合闭环系统在中东、北非和土耳其地区的真实世界表现
Mohammed Al-Sofiani,Wael Chaar,Tim van den Heuvel et al.
Mohammed Al-Sofiani et al.
Aims: Real-world evidence (RWE) data on the use of automated insulin delivery (AID) systems in the MENAT region (Middle East, North Africa, Türkiye) are limited. The aim of this article is to report RWE data on the use o...
Use of Automated Insulin Delivery Systems Following Pediatric Total Pancreatectomy and Islet Auto Transplantation [0.03%]
自动胰岛素输送系统在儿科全胰腺切除和胰岛自体移植术后中的应用
Neha Parimi,Samuel M Vanderhoek,Kristin Arcara et al.
Neha Parimi et al.
Total pancreatectomy with islet auto-transplantation (TPIAT) treats intractable pain in patients with pancreatitis. Automated insulin delivery (AID) systems improve glycemic control in patients with diabetes, but their role in post-TPIAT gl...
Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled Trial [0.03%]
算法连续葡萄糖监测在使用德谷胰岛素并由此调整降糖方案（有或无非胰岛素类降糖药）治疗2型糖尿病患者中的安全性和可行性：一项16周随机对照试验
Anas El Fathi,Ralf Nass,Carol J Levy et al.
Anas El Fathi et al.
Background: Continuous glucose monitoring (CGM) is increasing in insulin-treated type 2 diabetes (T2D). Yet, standardized CGM-based insulin titration is lacking. This study evaluated the feasibility of algorithmic CGM-bas...
Standardizing the Accuracy and Performance Evaluation Metrics of Integrated Continuous Glucose Monitors in the Asia-Pacific Region [0.03%]
亚太地区集成连续葡萄糖监测准确性和性能评估指标的标准化
Alice Pik-Shan Kong,Rimei Nishimura,Stephen M Twigg et al.
Alice Pik-Shan Kong et al.
Diabetes is a growing public health burden across the Asia-Pacific (APAC) region. The increasing use of continuous glucose monitoring (CGM) holds significant potential to improve glycemic control and safety outcomes in individuals with diab...
Glycemic Outcomes Following a Missed Premeal Bolus: A Comparative Study of Three Automated Insulin Delivery Systems in Children with Type 1 Diabetes [0.03%]
比较三种自动胰岛素输送系统在1型糖尿病患儿遗漏餐前大剂量给药后的血糖结局：一项对照研究
Alzbeta Santova,Lukas Plachy,Vit Neuman et al.
Alzbeta Santova et al.
Objective: Missing premeal boluses negatively impacts glycemic outcomes in automated insulin delivery (AID) users. This prospective interventional study compared postprandial glycemia after missed bolus across three AID s...
Automated Insulin Delivery Reduces the Risk of Diabetic Retinopathy in Adults with Type 1 Diabetes: A Prospective Cohort Study [0.03%]
成人1型糖尿病患者自动胰岛素输注可降低增殖性糖尿病视网膜病变发病风险：前瞻性队列研究
Lía Nattero-Chávez,Sara de Lope Quiñones,Alejandra Quintero Tobar et al.
Lía Nattero-Chávez et al.
Aims: To evaluate the impact of automated insulin delivery (AID) systems on the incidence and progression of diabetic retinopathy (DR) in adults with type 1 diabetes (T1D) compared with multiple daily injections (MDI). ...
MiniMedTM 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics [0.03%]
美敦力 MiniMed™ 780G 混合闭环系统改善了1型糖尿病患者的血管和内皮功能指标：与持续葡萄糖监测指标的相关性
Aikaterini Kountouri,Ignatios Ikonomidis,Konstantinos Katogiannis et al.
Aikaterini Kountouri et al.
Objective: Patients with type 1 diabetes (T1D) present early subclinical signs of vascular and endothelial dysfunction. Hybrid closed-loop systems (HCLSs) are the gold standard for glycemic management; however, their card...
Recommendations from the United Kingdom UNBIASED Study to Address Diabetes Technology Access Disparities for Children and Young People [0.03%]
英国UNBIASED研究针对儿童和年轻人糖尿病科技使用差异的建议
Sze May Ng,Natalie Darko,Eda Tonga et al.
Sze May Ng et al.
Aims: The UNBIASED UK study is the first national study that explores disparities in access to diabetes technology among children and young people (CYP) with type 1 diabetes (T1D) from ethnic minority and low socioeconomi...
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors as Adjunctive Therapy to Automated Insulin Delivery System in Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials [0.03%]
二肽基肽酶-4抑制剂、胰高血糖素样肽-1受体激动剂和钠-葡萄糖共转运蛋白-2抑制剂作为1型糖尿病自动化胰岛素输注系统辅助治疗的疗效和安全性：随机临床试验的系统评价和meta分析
Yongwen Zhou,Mengyun Lei,Qiongyan Lin et al.
Yongwen Zhou et al.
Aims: The efficacy of adding various noninsulin hypoglycemic drugs to automated insulin delivery (AID) systems in patients with type 1 diabetes (T1D) was investigated in randomized controlled trials (RCTs), yet no meta-an...
Efficacy and Safety of Oral GLP-1 RA Orforglipron on Weight and Glycemic Control According to Diabetes Status: A Systematic Review and Meta-Analysis [0.03%]
口服GLP-1受体激动剂orforglipron的疗效和安全性：根据糖尿病状态对体重和血糖控制的影响（系统评价和 meta 分析）
Noha Hammad,Aya M Ramadan,Ahmed Nazmy et al.
Noha Hammad et al.
Excess body weight and poor metabolic control remain major contributors to cardiometabolic disease, highlighting the need for effective therapeutic options. This meta-analysis aimed to evaluate the efficacy and safety of once-daily oral orf...